Your browser doesn't support javascript.
loading
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers.
Grill, Sabine; Yahiaoui-Doktor, Maryam; Basrai, Maryam; Struck, Joachim; Schulte, Janin; Berling-Ernst, Anika; Engel, Christoph; Ullrich, Mirjam; Lammert, Jacqueline; Bischoff, Stephan C; Schmidt, Thorsten; Niederberger, Uwe; Chronas, Dimitrios; Rhiem, Kerstin; Schmutzler, Rita; Halle, Martin; Kiechle, Marion.
Afiliação
  • Grill S; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum Rechts Der Isar, Technical University Munich (TUM), Munich, Germany. Sabine.Grill@tum.de.
  • Yahiaoui-Doktor M; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Basrai M; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • Struck J; SphingoTec GmbH, Hennigsdorf, Germany.
  • Schulte J; SphingoTec GmbH, Hennigsdorf, Germany.
  • Berling-Ernst A; Department of Prevention, Rehabilitation and Sports Medicine, Faculty of Medicine, University Hospital Rechts Der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Engel C; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Ullrich M; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum Rechts Der Isar, Technical University Munich (TUM), Munich, Germany.
  • Lammert J; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum Rechts Der Isar, Technical University Munich (TUM), Munich, Germany.
  • Bischoff SC; Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany.
  • Schmidt T; Comprehensive Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Niederberger U; Institute for Medical Psychology and Medical Sociology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Chronas D; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum Rechts Der Isar, Technical University Munich (TUM), Munich, Germany.
  • Rhiem K; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Schmutzler R; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Halle M; Department of Prevention, Rehabilitation and Sports Medicine, Faculty of Medicine, University Hospital Rechts Der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Kiechle M; Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, Klinikum Rechts Der Isar, Technical University Munich (TUM), Munich, Germany.
Breast Cancer Res Treat ; 186(3): 741-752, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33543354
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neurotensina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neurotensina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha